Reference check: November 7, 2026 · AI-assisted original research guidance · No human author or editorial approval claimed.
Ownership research should answer what was bought, who controls it and what the source actually establishes. Public company filings, strategic-buyer releases and investor portfolio pages are different evidence types. This guide provides an original diligence sequence for laboratory investors without recommending securities, inventing transaction multiples or treating historical portfolio entries as continuously current.
What the primary records support
Labcorp's August 5, 2024 release reports completion of a purchase of selected Invitae assets, rather than describing a purchase of the entire company.[1]
Evidence limit: Historical company transaction statement. Its expected clinical and integration benefits are not independently demonstrated outcomes; no price or liability-transfer conclusion is asserted.
Element's historical announcement says Temasek completed its acquisition from Bridgepoint, following the January 25, 2022 announcement.[2]
Evidence limit: A company release is attributed transaction evidence, not an independent valuation. It does not establish current ownership indefinitely or support an invented price or multiple.
NVLAP provides third-party accreditation to testing and calibration laboratories and assesses management and technical requirements against ISO/IEC 17025:2017.[3]
Evidence limit: A program description does not establish a particular laboratory's current accreditation, site, methods or scope.
01 / analytical method
Worked transaction perimeter: selected assets are not the whole company
The Labcorp release in the references is a completion source for selected Invitae assets. In a research ledger, record the buyer, original business, asset perimeter, closing source and date separately. Leave assumed liabilities and excluded businesses unresolved unless the purchase documents establish them. Do not carry a historical seller ticker into a current listing or attach later activities of the buyer to every former entity.
- Does the evidence describe selected assets, a subsidiary, shares or a merger?
- What terms remain undisclosed or require the underlying agreement?
02 / analytical method
Ownership timeline: buyer type is not an investment outcome
Separate the announcement, completion, ownership changes and later disposals. The Element–Temasek reference illustrates a historical closing statement; it is not a perpetual current-ownership certificate. Do not infer leverage, returns or an exit timetable simply because a buyer is a financial investor. Minority rights, control and management responsibilities require documentary support. The investor directory contains selected examples, not a comprehensive capital-flow dataset.
- What exact date and stake does each record support?
- Has a later filing changed the recorded ownership or perimeter?
03 / analytical method
Earnings comparability and risk worksheet
Compare periods using the issuer's definitions for currency, organic growth, acquired revenue, discontinued operations and adjustments. Keep disclosed numbers separate from calculations and forecasts. A seller's historic revenue is not automatically the acquired business's future revenue. Map concentration, debt maturity, reimbursement where applicable and integration commitments to their primary records; do not invent valuation inputs to fill missing disclosures.
- Is the denominator the same business perimeter in both periods?
- Which figures are reported, adjusted, forecast or independently calculated?
04 / analytical method
Service capability after the deal
Match the target's services to specific sites, instruments, scope and staff responsibilities. An acquisition announcement alone does not establish transfer of every accreditation or contract. Use original authorization records for capability claims and subsequent operating evidence for integration claims. Keep diligence notes private and use the protected blank checklist for a consistent review boundary. These methods are educational, not investment or legal advice.
- Which capabilities are evidenced for which operating site?
- What transition milestone has actually occurred rather than merely been promised?
Full primary references
- [1] Labcorp Finalizes Acquisition of Select Assets of Invitae · Labcorp · Published August 5, 2024, 7:00 AM EDT · Source checked 2026-11-07.
https://ir.labcorp.com/news-releases/news-release-details/labcorp-finalizes-acquisition-select-assets-invitae - [2] Element announces completion of its acquisition by Temasek · Element Materials Technology · Page labelled last edited July 5, 2022; separate original publication timestamp not established · Source checked 2026-11-07.
https://www.element.com/about-element/news/2022/07/05/element-announces-completion-of-its-acquisition-by-temasek - [3] National Voluntary Laboratory Accreditation Program · NIST · Undated program page · Source checked 2026-11-07.
https://www.nist.gov/nvlap
Dates describe the original record or its stated revision, not a new event. Source checking is not legal advice, product certification, plagiarism clearance or human editorial approval. Editorial standards · Send a documented correction.